GNFT: Genfit SA Company Short-Term Debt

Symbol and logo of brand Genfit SA (GNFT)

Current price action for Genfit S.A. (GNFT) reflects a current short-term debt metric of 0.00. The business focuses on developing therapies for liver pathologies. Patents for diagnostics and centers in France and the US ensure stability. Growth is driven by licensing agreements and joint R&D projects with global behemoths without pursuing merger deals.

GNFT (genfit.com) Company Short-Term Debts history from 07/04/2022 to 12/06/2025

Genfit SA - analytical breakdowns and key metrics (GNFT)

- current quotes and average value forecast:
Price Chart Genfit Corp|GNFT - Fair Value Consensus
- market capitalization information:
Market Value GENFIT|GNFT - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Genfit S.A.|GNFT - Book Capitalization|Market Cap to Net Assets Ratio genfit.com|GNFT - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Genfit S.A.|GNFT - Long-Term Debt to Equity|Short-Term Debt to Capital Genfit Corp|GNFT - Company Total Debt Obligations|Debt to Book Value GENFIT|GNFT - Company Long-Term Debt|Company Short-Term Debts Genfit S.A.|Quick Liquidity genfit.com
- net income and valuation multiples indicators:
GNFT - Final Profit
Fundamental company analysis:genfit.com - GNFT
Mass-produced product of Genfit SA

Genfit S.A. focuses on laboratory development of liver therapy drugs while adhering to strict FDA safety protocols. The trend in total short-term debt reflects the issuer's obligations with maturities of up to one year. This metric captures current liquidity, excluding temporary gaps between quarterly reports. A reduction in the debt load minimizes financial risks, although a sharp decline may indicate a reduction in the credit limit. This determines the overall capital stability of the company.

Competitor analysis for Genfit S.A.

ARWR - Company Short-Term Debt|Company Short-Term Loans and Borrowings MIRM (Mirum Pharmaceuticals, Inc.)|Dynavax (DVAX) - Company Short-Term Debt|Company Current Liabilities Tekmira Pharmaceuticals|IVA (Inventiva S.A.) - Company Short-Term Debts|Company Short-Term Debts gyretx.com|Company Current Liabilities ASMB (Assembly Biosciences, Inc.)|GALT (galectintherapeutics.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt DURECT DRRX|Aligos Therapeutics Inc. - Company Short-Term Debt|BioVie Pharma - Company Short-Term Debts|Short-Term Debt Volume Galmed Pharmaceuticals GLMD|NDRA (ENDRA Life Sciences Inc.) - Company Current Liabilities|HEPA (Hepion Pharmaceuticals, Inc.) - Company Short-Term Debt